ArticleThoracic cancer2025

Efficacy and Safety of Low-Dose Oral Etoposide Combined With Capecitabine for Patients With Postoperative Metastatic Breast Cancer Resistant to Anthracycline/Taxanes.

Xue Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.